Post-marketing Clinical Study of Onglyza Tablet
Phase 4
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-jRCT1080222299
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1) Subjects with a diagnosis of type 2 diabetes mellitus.
2) Subjects who have been undergoing dietary and exercise therapy and have not taken any oral antihyperglycemic medications for more than 12 weeks prior to initiation of study treatment.
Exclusion Criteria
1) Subjects with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety and efficacy
- Secondary Outcome Measures
Name Time Method